Surat, India —October 30, 2009 – Sahajanand Medical Technologies, a leading developer and manufacturer of Drug Eluting Stents, announced that the Journal of the WILEY inter science - Catheterization and Cardiovascular Interventions (CCI) has published 1 year results from the PAINT trial (ClinicalTrails.gov ID: NCT00752362). The article entitled “Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (Paclitaxel or Sirolimus) ...

XClinical is an active contributor to CDISC Interchange North America in Baltimore XClinical GmbH, Munich, Germany – Oct 26, 2009 – XClinical, a European vendor of innovative software products for eClinical trials, today announced its participation in the CDISC Interchange North America “Today’s experiences and tomorrow’s expectations” taking place in Baltimore from November 9th to November 13th. During the exhibition XClinical’s experts will be available at booth #15 for de ...

One of XClinical’s customers, the Munich-based CRO OSE Oncology Services Europe S.a.r.l., has just started a large clinical trial for one of Europe’s premier pharmaceutical companies. XCLINICAL GMBH, Munich, Germany – May 14, 2008 – XClinical, a European vendor of innovative software products for eClinical trials, announced the use of MARVIN, its CDISC ODM certified EDC solution, in a large European multicentric clinical trial conducted by its Munich-based customer, OSE Oncology Services ...

XClinical executives will be presenting at two important CDISC European User Group Meetings in January 2008. XCLINICAL GMBH, Munich, Germany – Dec. 12, 2007 – XClinical, a continuously growing private company and a global provider of electronic data capture (EDC), CDM, and CTM, today announced the invitation to two important industry events, the CDISC User Group Meetings in January 2008. XClinical executives will discuss key issues regarding ODM in clinical trials in presentations at ...